B-186 14-3-3eta as a Biomarker for Disease Severity and Prognosis in Rheumatoid Arthritis: A Longitudinal Single-Centre Cohort Study
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammatory arthritis. While rheumatoid factor (RF) and/or anti–cyclic citrullinated peptide (anti-CCP) antibodies help identify RA patients, 20–30% are seronegative for these two markers creating diagnostic and prognostic challenges. Th...